CGTLive’s Weekly Rewind – May 20, 2022

Review top news and interview highlights from the week ending May 20, 2022.

Around the Helix at ASGCT: Cell and Gene Therapy Company Updates – May 18, 2022

Catch up on the latest news and announcements in cell and gene therapies presented at the annual ASGCT meeting.

X-Linked Retinitis Pigmentosa Gene Therapy Improves BCVA

Interim data from the phase 2 Skyline trial demonstrated a 62.5% response rate.